acetic acid has been researched along with canagliflozin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayoumi, AMA; Ibrahim, YF; Khalaf, HM; Khalifa, EMMA; Morsy, MA; Rifaai, RA | 1 |
| Abdelhamid, AM; Amin, NA; Cavalu, S; El-Ahwany, E; El-Azez, RA; El-Rafi, AA; El-Sandarosy, R; Elagamy, HI; Essam, M; Essam, N; Gaafar, AGA; Girgis, S; Hasaballah, A; Kamal, I; Mahmoud, F; Mansour, M; Mohamed, D; Mohammed, OA; Nasr, M; Rizk, H; Saber, S; Youssef, ME | 1 |
2 other study(ies) available for acetic acid and canagliflozin
| Article | Year |
|---|---|
Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2.
Topics: Acetic Acid; Animals; Antioxidants; Canagliflozin; Colitis; Colon; Glucose; Male; NADPH Oxidase 2; Organ Size; Oxidative Stress; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Sulfasalazine | 2021 |
Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis.
Topics: Acetic Acid; AMP-Activated Protein Kinases; Animals; Canagliflozin; Chitosan; Colitis; Colitis, Ulcerative; Colon; Cytokines; Hyaluronic Acid; Microspheres; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Signal Transduction | 2022 |